Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement

References

• Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:853-61; PMID:21075057; http://dx.doi.org/10.1016/S1473-3099(10)70251-6
   PubMed Web of Science ®Google Scholar
• ECDC, 2013. Annual epidemiological report Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Available at: http://www.ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2013.pdf [Accessed 10 February 2015].
   Google Scholar
• Soriano-Gabarro M, Wolter J, Hogea C, Vyse A. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Rev Anti Infect Ther 2011; 9:761-74; PMID:21905785; http://dx.doi.org/10.1586/eri.11.89
   PubMed Web of Science ®Google Scholar
• Zahlanie YC, Hammadi MM, Ghanem ST, Dbaibo GS. Review of meningococcal vaccines with updates on immunization in adults. Hum Vaccin Immunother 2014; 10:995-1007; PMID:24500529; http://dx.doi.org/10.4161/hv.27739
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1-28; PMID:23515099
   PubMed Web of Science ®Google Scholar
• Martin NG, Snape MD. A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn? Expert Rev Vaccines 2013; 12:837-58; PMID:23984957; http://dx.doi.org/10.1586/14760584.2013.814862
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines-an unfinished story. Lancet Infect Dis 2010; 10:112-24; PMID:20113980; http://dx.doi.org/10.1016/S1473-3099(09)70324-X
   PubMed Web of Science ®Google Scholar
• Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 2012; 30 Suppl 2:B87-97; PMID:22607904; http://dx.doi.org/10.1016/j.vaccine.2012.01.033
   PubMed Web of Science ®Google Scholar
• Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 2009; 8:851-61; PMID:19538112; http://dx.doi.org/10.1586/erv.09.48
   PubMed Web of Science ®Google Scholar
• Maiden MC, Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 2002; 359:1829-31; PMID:12044380; http://dx.doi.org/10.1016/S0140-6736(02)08679-8
   PubMed Web of Science ®Google Scholar
• Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, Heath PT, Lewis DJ, Pollard AJ, Turner DP, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet 2014; 384:2123-31; PMID:25145775; http://dx.doi.org/10.1016/S0140-6736(14)60842-4
   PubMed Web of Science ®Google Scholar
• Bexsero: Summary of product characteristics. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002333/WC500137881.pdf [Accessed 10 February 2015].
   Google Scholar
• Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 2013; 13:416-25; PMID:23414709; http://dx.doi.org/10.1016/S1473-3099(13)70006-9
   PubMed Web of Science ®Google Scholar
• Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012; 307:573-82; PMID:22318278; http://dx.doi.org/10.1001/jama.2012.85
   PubMed Web of Science ®Google Scholar
• Santolaya ME, O'Ryan ML, Valenzuela MT, Prado V, Vergara R, Munoz A, Toneatto D, Grana G, Wang H, Clemens R, et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 2012; 379:617-24; PMID:22260988; http://dx.doi.org/10.1016/S0140-6736(11)61713-3
   PubMed Web of Science ®Google Scholar
• Vesikari T, Esposito S, Prymula R, Ypma E, Kohl I, Toneatto D, Dull P, Kimura A. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013; 381:825-35; PMID:23324563; http://dx.doi.org/10.1016/S0140-6736(12)61961-8
   PubMed Web of Science ®Google Scholar
• Claus H, Borrow R, Taha M-K, Hong E, Gilchrist S, Findlow J, Lucidarme J, Orlandi L, Rigat F, Serruto D, et al. Potential coverage of the 4CMenB vaccine in non-B meningococci. XVIIIth International Pathogenic Neisseria Conference (IPNC). Würzburg, Germany, 2012.
   Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11:760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1
   PubMed Web of Science ®Google Scholar
• Kayhty H, Auranen K, Nohynek H, Dagan R, Makela H. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines 2006; 5:651-67; PMID:17181439; http://dx.doi.org/10.1586/14760584.5.5.651
   PubMed Web of Science ®Google Scholar
• Trotter CL, Gay NJ, Edmunds WJ. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol 2005; 162:89-100; PMID:15961591; http://dx.doi.org/10.1093/aje/kwi160
   PubMed Web of Science ®Google Scholar
• Christensen H, Hickman M, Edmunds WJ, Trotter CL. Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine 2013; 31:2638-46; PMID:23566946; http://dx.doi.org/10.1016/j.vaccine.2013.03.034
   PubMed Web of Science ®Google Scholar
• Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ. Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis 2010; 10:90; PMID:20377886; http://dx.doi.org/10.1186/1471-2334-10-90
   PubMed Web of Science ®Google Scholar
• Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, Pelton SI, Hausdorff WP. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination. Vaccine 2010; 28:3650-60; PMID:20359560; http://dx.doi.org/10.1016/j.vaccine.2010.03.030
   PubMed Web of Science ®Google Scholar
• Maiden MC, Ibarz-Pavon AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 2008; 197:737-43; PMID:18271745; http://dx.doi.org/10.1086/527401
   PubMed Web of Science ®Google Scholar
• Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev 2007; 31:52-63; PMID:17233635; http://dx.doi.org/10.1111/j.1574-6976.2006.00052.x
   PubMed Web of Science ®Google Scholar
• Krizova P, Kalmusova J, Musilek M, Felsberg J, Haugvicova R, Vlckova J. [Study of long-term and multiple carriage of Neisseria meningitidis in a healthy population using molecular biology methods]. Epidemiol Mikrobiol Imunol 2004; 53:25-36; PMID:15052832
   PubMedGoogle Scholar
• Martcheva M, Pilyugin SS, Holt RD. Subthreshold and superthreshold coexistence of pathogen variants: the impact of host age-structure. Math Biosci 2007; 207:58-77; PMID:17087980; http://dx.doi.org/10.1016/j.mbs.2006.09.010
   PubMed Web of Science ®Google Scholar
• Racloz VN, Luiz SJ. The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology. BMC Infect Dis 2010; 10:175; PMID:20565757; http://dx.doi.org/10.1186/1471-2334-10-175
   PubMed Web of Science ®Google Scholar
• Bettinger JA, Deeks SL, Halperin SA, Tsang R, Scheifele DW. Controlling serogroup B invasive meningococcal disease: the Canadian perspective. Expert Rev Vaccines 2013; 12:505-17; PMID:23659299; http://dx.doi.org/10.1586/erv.13.30
   PubMed Web of Science ®Google Scholar
• Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, Alvestad T, Jolley KA, Wilson DJ, McCarthy ND, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004; 42:5146-53; PMID:15528708; http://dx.doi.org/10.1128/JCM.42.11.5146-5153.2004
   PubMed Web of Science ®Google Scholar
• Bogaert D, Hermans PW, Boelens H, Sluijter M, Luijendijk A, Rumke HC, Koppen S, van Belkum A, de Groot R, Verbrugh HA. Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children. Clin Infect Dis 2005; 40:899-902; PMID:15736029; http://dx.doi.org/10.1086/428351
   PubMed Web of Science ®Google Scholar
• Leimkugel J, Hodgson A, Forgor AA, Pfluger V, Dangy JP, Smith T, Achtman M, Gagneux S, Pluschke G. Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med 2007; 4:e101; PMID:17388665; http://dx.doi.org/10.1371/journal.pmed.0040101
   PubMed Web of Science ®Google Scholar
• Frosch M, Maiden MCJ. Handbook of meningococcal disease : infection biology, vaccination, clinical management Germany: Weinheim : Wiley-VCH, 2008.
   Google Scholar
• Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074
   PubMed Web of Science ®Google Scholar
• Goeyvaerts N, Hens N, Ogunjimi B, Aerts M, Shkedy Z, Damme PV, Beutels P. Estimating infectious disease parameters from data on social contacts and serological status. J Royal Statist Soc Series C: Applied Statistics 2010; 59:255-77; http://dx.doi.org/10.1111/j.1467-9876.2009.00693.x
   Web of Science ®Google Scholar
• Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 2006; 164:936-44; PMID:16968863; http://dx.doi.org/10.1093/aje/kwj317
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Colijn C, Cohen T, Hanage WP, Fraser C. No coexistence for free: neutral null models for multistrain pathogens. Epidemics 2009; 1:2-13; PMID:21352747; http://dx.doi.org/10.1016/j.epidem.2008.07.001
   PubMed Web of Science ®Google Scholar
• Trotter CL, Gay NJ, Edmunds WJ. The natural history of meningococcal carriage and disease. Epidemiol Infect 2006; 134:556-66; PMID:16238823; http://dx.doi.org/10.1017/S0950268805005339
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Hens N, Goeyvaerts N, Aerts M, Van Damme P, Beutels P. Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella. Math Biosci 2009; 218:80-7; PMID:19174173; http://dx.doi.org/10.1016/j.mbs.2008.12.009
   PubMed Web of Science ®Google Scholar
• Sutton KL, Banks HT, Castillo-Chavez C. Public vaccination policy using an age-structured model of pneumococcal infection dynamics. J Biol Dyn 2010; 4:176-95; PMID:22876985; http://dx.doi.org/10.1080/17513750903023715
   PubMedGoogle Scholar
• Coen PG, Cartwright K, Stuart J. Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica. Int J Epidemiol 2000; 29:180-8; PMID:10750621; http://dx.doi.org/10.1093/ije/29.1.180
   PubMed Web of Science ®Google Scholar
• Wise J. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. BMJ 2014; 348:g2327; PMID:24665138; http://dx.doi.org/10.1136/bmj.g2327
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Laboratory confirmed cases of all invasive meningococcal disease by serogroup, age and epidemiological year, England and Wales. Available at: https://www.gov.uk/government/collections/meningococcal-disease-guidance-data-and-analysis [Accessed 10 February 2015].
   Google Scholar
• Hogea C, Effelterre TV, Vyse A, Kriz P, Soriano-Gabarró M. Neisseria meningitidis: A baseline dynamic transmission model for the Czech Republic. 28th Annual ESPID Meeting; Nice, France; 2010.
   Google Scholar
• UK's Office for National Statistics. Population Estimates by Age and Sex. Available at: http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Population +Estimates+by+Age+and+Sex [Accessed 10 February 2015].
   Google Scholar
• Czech Statistical Office. Czech Demagraphic Handbook 2007. Available at: http://csugeo.i-server.cz/csu/2008edicniplan.nsf/engpubl/4032-08-2007 [Accessed 10 February 2015].
   Google Scholar